Scoop Analysis

Scoop offers an AI-native platform designed for drafting and maintaining regulatory submissions, particularly for pre-clinical Investigational New Drug (IND) filings. The main product features include:

1. AI-Native Drafting: Automates the generation of regulatory documents by converting study and manufacturing data into dynamic formats that are continuously updated.
2. Continuous Maintenance: Ensures that regulatory documents remain current with scientific advancements, reducing the risk of outdated information.
3. Automated Module Drafting: Facilitates the drafting, formatting, and cross-referencing of regulatory documents, allowing teams to focus on strategic aspects rather than administrative tasks.
4. Version Control and Updates: Provides continuous versioning and updates to documents, ensuring that all changes are tracked and managed effectively.
5. Citation Visibility: Enhances the clarity of references within documents, making it easier for reviewers to verify information.
6. Automatic Inconsistency Detection: Identifies discrepancies across different modules, improving the accuracy of submissions.

These features collectively enhance the efficiency and accuracy of regulatory submissions, making it a valuable tool for regulatory affairs teams, consultants, and contract research organizations (CROs).